BG
IMMU

BlackRock Group’s Immunomedics Inc IMMU Stock Holding History

BlackRock Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$224K Buy
60,836
+9,712
+19% +$28.7K ﹤0.01% 2630
2016
Q3 		$166K Buy
51,124
+4,162
+9% +$11.6K ﹤0.01% 2686
2016
Q2 		$109K Buy
46,962
+24,444
+109% +$81.7K ﹤0.01% 2772
2016
Q1 		$56K Buy
22,518
+13,550
+151% +$30.5K ﹤0.01% 2897
2015
Q4 		$28K Hold
8,968
– – ﹤0.01% 2904
2015
Q3 		$15K Buy
+8,968
New +$22.9K ﹤0.01% 3005
2014
Q4 		– Sell
-4,492
Closed -$17K – 2929
2014
Q3 		$17K Buy
+4,492
New +$15.2K ﹤0.01% 2762
2014
Q2 		– Sell
-34,288
Closed -$144K – 2891
2014
Q1 		$144K Hold
34,288
– – ﹤0.01% 2525
2013
Q4 		$158K Buy
34,288
+15,899
+86% +$70.8K ﹤0.01% 2450
2013
Q3 		$114K Buy
+18,389
New +$106K ﹤0.01% 2588

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock Group's IMMU Position: Q4 2016 in Review

BlackRock Group increased its Immunomedics Inc (IMMU) stake by 19% in Q4 2016, buying an estimated $28.7K and bringing the position to 60,836 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

BlackRock Group first reported a position in IMMU in Q3 2013 and has held it in 10 quarters since. 109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • BlackRock Group held 60,836 shares of Immunomedics Inc worth $224K as of Q4 2016.
  • BlackRock Group bought 9,712 Immunomedics Inc shares in Q4 2016, an estimated $28.7K.
  • Immunomedics Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2630 holding.
  • BlackRock Group first reported a position in Immunomedics Inc in Q3 2013 and has held it in 10 quarters since.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.